An International Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children.
Who should be tested Initial screening Subsequent evaluations
A review of published data regarding the use of aromatase inhibitors in pediatrics.
Members of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of
rhGH.
A Scientific Statement from the American Heart Association on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents.
